225 related articles for article (PubMed ID: 33295414)
1. A comparison of IL-17 and IL-34 concentrations in the cerebrospinal fluid of patients with acute inflammatory demyelinating neuropathy and chronic inflammatory demyelinating polyneuropathy.
Soytürk H; Yılmaz M
Rev Assoc Med Bras (1992); 2020 Nov; 66(11):1583-1588. PubMed ID: 33295414
[TBL] [Abstract][Full Text] [Related]
2. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
[TBL] [Abstract][Full Text] [Related]
3. Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
Front Immunol; 2023; 14():1241199. PubMed ID: 38077366
[TBL] [Abstract][Full Text] [Related]
4. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
5. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Pashenkov M; Jin JP; Link H
J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
[TBL] [Abstract][Full Text] [Related]
6. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP.
Breville G; Lascano AM; Roux-Lombard P; Vuilleumier N; Lalive PH
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34140310
[TBL] [Abstract][Full Text] [Related]
8. High Levels of Il-19 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy.
Sangsefidi S; Ghafouri-Fard S; Komaki A; Mazdeh M; Taheri M; Eftekharian MM
J Mol Neurosci; 2020 Dec; 70(12):1997-2000. PubMed ID: 32472395
[TBL] [Abstract][Full Text] [Related]
9. Increased Levels of IL-34 in Acquired Immune-Mediated Neuropathies.
Rezaei S; Ghafouri-Fard S; Komaki A; Mazdeh M; Taheri M; Eftekharian MM
J Mol Neurosci; 2021 Jan; 71(1):137-141. PubMed ID: 32588399
[TBL] [Abstract][Full Text] [Related]
10. Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies.
Kmezic I; Samuelsson K; Finn A; Upate Z; Blennow K; Zetterberg H; Press R
Eur J Neurol; 2022 Sep; 29(9):2810-2822. PubMed ID: 35638376
[TBL] [Abstract][Full Text] [Related]
11. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
15. [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Kanbayashi T; Sonoo M
Brain Nerve; 2015 Nov; 67(11):1388-96. PubMed ID: 26560954
[TBL] [Abstract][Full Text] [Related]
16. A study on the role of serum uric acid in differentiating acute inflammatory demyelinating polyneuropathy from acute-onset chronic inflammatory demyelinating polyneuropathy.
Zhang W; Tao W; Wang J; Nie P; Duan L; Yan L
Eur J Neurol; 2024 May; 31(5):e16222. PubMed ID: 38356316
[TBL] [Abstract][Full Text] [Related]
17. CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS.
Capodivento G; De Michelis C; Carpo M; Fancellu R; Schirinzi E; Severi D; Visigalli D; Franciotta D; Manganelli F; Siciliano G; Beronio A; Capello E; Lanteri P; Nobile-Orazio E; Schenone A; Benedetti L; Nobbio L
J Neurol Neurosurg Psychiatry; 2021 Mar; 92(3):303-310. PubMed ID: 33093191
[TBL] [Abstract][Full Text] [Related]
18. Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy.
Tan CY; Yahya MA; Goh KJ; Shahrizaila N
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109705
[No Abstract] [Full Text] [Related]
19. Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy.
Chaudhary UJ; Rajabally YA
J Neurol; 2021 Apr; 268(4):1366-1373. PubMed ID: 33170339
[TBL] [Abstract][Full Text] [Related]
20. IL-8 as a potential biomarker in Guillain-Barre Syndrome.
Breville G; Lascano AM; Roux-Lombard P; Lalive PH
Eur Cytokine Netw; 2019 Dec; 30(4):130-134. PubMed ID: 32096474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
